Antibodies and α-synuclein: What to target against Parkinson's Disease?
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibodies and α-synuclein: What to target against Parkinson's Disease?
Authors
Keywords
-
Journal
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
Volume -, Issue -, Pages 140943
Publisher
Elsevier BV
Online
2023-10-01
DOI
10.1016/j.bbapap.2023.140943
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Who Ever Said It Would Be Easy? Reflecting on Two Clinical Trials Targeting α‐Synuclein
- (2023) Poul Henning Jensen et al. MOVEMENT DISORDERS
- Microfluidic antibody affinity profiling of alloantibody-HLA interactions in human serum
- (2023) Matthias M. Schneider et al. BIOSENSORS & BIOELECTRONICS
- Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
- (2023) Andrew Siderowf et al. LANCET NEUROLOGY
- Protocol to determine antibody affinity and concentration in complex solutions using microfluidic antibody affinity profiling
- (2023) Marc Emmenegger et al. STAR Protocols
- Passive Immunization in Alpha-Synuclein Preclinical Animal Models
- (2022) Jonas Folke et al. Biomolecules
- The C-terminal tail of α-synuclein protects against aggregate replication but is critical for oligomerization
- (2022) Azad Farzadfard et al. Communications Biology
- Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition
- (2022) Azad Farzadfard et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Trial of Prasinezumab in Early-Stage Parkinson’s Disease
- (2022) Gennaro Pagano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Cinpanemab in Early Parkinson’s Disease
- (2022) Anthony E. Lang et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGCG has Dual and Opposing Effects on the N-terminal Region of Self-associating α-synuclein Oligomers
- (2022) Anne Louise Grønnemose et al. JOURNAL OF MOLECULAR BIOLOGY
- Alpha-Synuclein Antibody Characterization: Why Semantics Matters
- (2021) Tiago Fleming Outeiro MOLECULAR NEUROBIOLOGY
- α-Helical peptidic scaffolds to target α-synuclein toxic species with nanomolar affinity
- (2021) Jaime Santos et al. Nature Communications
- Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update
- (2021) E. Maruthi Prasad et al. Pharmaceuticals
- Lipid Peroxidation Products HNE and ONE Promote and Stabilize Alpha-Synuclein Oligomers by Chemical Modifications
- (2021) Camilla Andersen et al. BIOCHEMISTRY
- Neurotoxic or neuroprotective: Post-translational modifications of α-synuclein at the cross-roads of functions
- (2021) Joshna Gadhavi et al. BIOCHIMIE
- Microfluidics and the quantification of biomolecular interactions
- (2021) Daniel E. Otzen et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Development of a universal nanobody-binding Fab module for fiducial-assisted cryo-EM studies of membrane proteins
- (2021) Joël S. Bloch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural and Functional Insights into α-Synuclein Fibril Polymorphism
- (2021) Surabhi Mehra et al. Biomolecules
- Alpha-Synuclein Aggregation in Parkinson's Disease
- (2021) E. Srinivasan et al. Frontiers in Medicine
- Generation of Monoclonal Antibodies against Phosphorylated α-Synuclein at Serine 129: Research Tools for Synucleinopathies
- (2020) Muneera Fayyad et al. NEUROSCIENCE LETTERS
- Accelerated Amyloid Beta Pathogenesis by Bacterial Amyloid FapC
- (2020) Ibrahim Javed et al. Advanced Science
- Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
- (2020) Sara Linse et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology
- (2020) Senthil T. Kumar et al. NEUROBIOLOGY OF DISEASE
- Two conformationally distinct α-synuclein oligomers share common epitopes and the ability to impair long-term potentiation
- (2019) Femke van Diggelen et al. PLoS One
- α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis
- (2019) Surabhi Mehra et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Antibodies against alpha‐synuclein: tools and therapies
- (2019) Nishant N. Vaikath et al. JOURNAL OF NEUROCHEMISTRY
- Autonomic Dysfunction in α-Synucleinopathies
- (2019) José Javier Mendoza-Velásquez et al. Frontiers in Neurology
- α‐synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities
- (2019) Parvez Alam et al. JOURNAL OF NEUROCHEMISTRY
- Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis
- (2019) Per Borghammer et al. Journal of Parkinsons Disease
- Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders
- (2019) Anne Messer et al. NEUROBIOLOGY OF DISEASE
- Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody
- (2018) Stina Syvänen et al. Alzheimers Research & Therapy
- Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models
- (2018) Andreas Weihofen et al. NEUROBIOLOGY OF DISEASE
- T cells from patients with Parkinson’s disease recognize α-synuclein peptides
- (2017) David Sulzer et al. NATURE
- Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers
- (2017) Giuliana Fusco et al. SCIENCE
- α-Synuclein Oligomers: A Study in Diversity
- (2016) Femke van Diggelen et al. ISRAEL JOURNAL OF CHEMISTRY
- Molecular mechanisms of protein aggregation from global fitting of kinetic models
- (2016) Georg Meisl et al. Nature Protocols
- Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein
- (2016) Marcus D Tuttle et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Pathological -synuclein transmission initiated by binding lymphocyte-activation gene 3
- (2016) X. Mao et al. SCIENCE
- Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer’s disease
- (2016) Dag Sehlin et al. Nature Communications
- Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein
- (2016) Marcus D Tuttle et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans
- (2016) Shu G. Chen et al. Scientific Reports
- Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
- (2015) Nishant N. Vaikath et al. NEUROBIOLOGY OF DISEASE
- Co-existence of Two Different α-Synuclein Oligomers with Different Core Structures Determined by Hydrogen/Deuterium Exchange Mass Spectrometry
- (2014) Wojciech Paslawski et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- How Epigallocatechin Gallate Can Inhibit α-Synuclein Oligomer Toxicityin Vitro
- (2014) Nikolai Lorenzen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synucleins Regulate the Kinetics of Synaptic Vesicle Endocytosis
- (2014) K. J. Vargas et al. JOURNAL OF NEUROSCIENCE
- The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid Formation
- (2014) Nikolai Lorenzen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
- (2014) Brian Spencer et al. MOLECULAR THERAPY
- Chaperone-mediated autophagy: roles in disease and aging
- (2013) Ana Maria Cuervo et al. CELL RESEARCH
- Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
- (2013) Elvira Valera et al. PHARMACOLOGY & THERAPEUTICS
- Structural and functional characterization of two alpha-synuclein strains
- (2013) Luc Bousset et al. Nature Communications
- Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia
- (2013) Changyoun Kim et al. Nature Communications
- Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies
- (2012) Shubhada N. Joshi et al. mAbs
- Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
- (2011) Eliezer Masliah et al. PLoS One
- Low-resolution structure of a vesicle disrupting -synuclein oligomer that accumulates during fibrillation
- (2011) L. Giehm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm
- (2010) Erik Kvam et al. PROTEIN ENGINEERING DESIGN & SELECTION
- The Influence of Vesicle Size and Composition on α-Synuclein Structure and Stability
- (2009) Lars Kjaer et al. BIOPHYSICAL JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search